ENDRA Life Sciences Inc.
NDRA
$5.50
-$0.42-7.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.60M | -1.23M | -1.04M | -4.15M | -2.35M |
| Total Depreciation and Amortization | 39.40K | 32.80K | 45.60K | 46.40K | 54.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 412.00K | 26.70K | -325.50K | 2.38M | 873.80K |
| Change in Net Operating Assets | -19.40K | 52.80K | 23.10K | 211.10K | -230.90K |
| Cash from Operations | -1.16M | -1.11M | -1.29M | -1.52M | -1.66M |
| Capital Expenditure | 0.00 | 0.00 | -17.30K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -17.30K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 149.50K | 857.40K | 145.80K | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.32M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 1.32M |
| Cash from Financing | 149.50K | 857.40K | 145.80K | 0.00 | 1.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Net Change in Cash | -1.01M | -256.30K | -1.16M | -1.52M | -1.66M |